|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| C07D 403/14 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/53 | (2006.01) | ||
| A61K 31/506 | (2006.01) | ||
| A61K 31/4439 | (2006.01) |
| (11) | Number of the document | 3371171 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16794885.0 |
| Date of filing the European patent application | 2016-11-01 | |
| (97) | Date of publication of the European application | 2018-09-12 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-25 |
| (46) | Date of publication of the claims translation | 2024-01-10 |
| (86) | Number | PCT/US2016/059879 |
| Date | 2016-11-01 |
| (87) | Number | WO 2017/079140 |
| Date | 2017-05-11 |
| (30) | Number | Date | Country code |
| 201562249784 P | 2015-11-02 | US | |
| 201662367960 P | 2016-07-28 | US |
| (72) |
BRUBAKER, Jason, D. , US
KIM, Joseph, L. , US
WILSON, Kevin, J. , US
WILSON, Douglas , US
DIPIETRO, Lucian, V. , US
|
| (73) |
Blueprint Medicines Corporation ,
45 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Vitalija BANAITIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | RET inhibitoriai |
| INHIBITORS OF RET |
| Payment date | Validity (years) | Amount | |
| 2024-09-26 | 9 | 208.00 EUR |
| 2025-11-01 |